JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.00469-07v1
45/7/2278    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S. X.
Right arrow Articles by Katz, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S. X.
Right arrow Articles by Katz, K. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2007, p. 2278-2280, Vol. 45, No. 7
0095-1137/07/$08.00+0     doi:10.1128/JCM.00469-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Comparison of Two Versions of the IDI-MRSA Assay Using Charcoal Swabs for Prospective Nasal and Nonnasal Surveillance Samples{triangledown}

Sean X. Zhang,1 Steven J. Drews,2 Joanne Tomassi,4 and Kevin C. Katz1,3,4*

Department of Laboratory Medicine and Pathobiology, University of Toronto,1 Ontario Public Health Laboratories,2 Infection Prevention and Control,3 Department of Laboratory Medicine, North York General Hospital, Toronto, Ontario, Canada4

Received 1 March 2007/ Returned for modification 4 May 2007/ Accepted 11 May 2007

An updated IDI-MRSA assay version was released to address the assay's low positive predictive value (PPV). A prospective analysis of two assay versions indicated no significant improvement in the PPV. Colonization by methicillin-resistant Staphylococcus aureus in 24% of patients would not have been detected if only nasal samples had been tested, as approved, by this molecular method.

* Corresponding author. Mailing address: Department of Laboratory Medicine, North York General Hospital, 4001 Leslie St., Suite GW-33, Toronto M2K1E1, Canada. Phone: (416) 756-6130. Fax: (416) 756-6449. E-mail: kkatz{at}nygh.on.ca

{triangledown} Published ahead of print on 23 May 2007.

Journal of Clinical Microbiology, July 2007, p. 2278-2280, Vol. 45, No. 7
0095-1137/07/$08.00+0     doi:10.1128/JCM.00469-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.